6
Jul 2026
Thirty years of data reveal changing heart health trends in obesity
A study reveals narrowing gaps in blood pressure and cholesterol between obesity and normal BMI, highlighting evolving cardiometabolic risks over three decades.
6
Jul 2026
A study reveals narrowing gaps in blood pressure and cholesterol between obesity and normal BMI, highlighting evolving cardiometabolic risks over three decades.
6
Jul 2026
MGI Tech showcases cutting-edge laboratory automation solutions at SLAS 2026, enhancing research efficiency and simplifying complex workflows in life sciences.
6
Jul 2026
At ESHG 2026, MGI Tech presents cutting-edge genomics solutions, emphasizing automation and partnerships to enhance clinical workflows and precision medicine.
6
Jul 2026
Introducing Go Spatial: MGI's automated workflow for high-resolution spatial transcriptomics, streamlining research in oncology, neuroscience, and beyond.
6
Jul 2026
MGI's Genoria AI and Shanghai AI Laboratory launch ProtoPilot and BioLab Bench, revolutionizing lab automation with Physical AI for life sciences.
6
Jul 2026
Daily voice recordings reveal early signs of asthma and COPD exacerbations, suggesting voice analysis could enhance remote monitoring and treatment timing.
6
Jul 2026
Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile dysfunction, impacting men's health.
5
Jul 2026
A major new study suggests that age-related changes in the uterus may contribute to poorer pregnancy outcomes, with women aged 49 and over experiencing lower live birth rates and higher miscarriage risk despite donor-oocyte treatment.
5
Jul 2026
A systematic review and meta-analysis of 28 cohort-based studies found a weak but statistically significant association between allergic diseases and later cancer incidence. The signal was strongest in the Western Pacific region and among people with asthma, but high heterogeneity and limited subgroup evidence mean the findings require caution.
5
Jul 2026
A new study developed a snore-source classification model that uses STFT spectrograms, pretrained CNN features, and an L2-regularized SVM to identify where snoring originates in the upper airway. Tested on the MPSSC dataset, the approach achieved a 67.1% test-set unweighted average recall, the highest value among the compared methods, but still needs external clinical validation.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more